Reyvow vs. Zecuity

Reviewed on 10/28/2019

Are Reyvow and Zecuity the Same Thing?

Reyvow (lasmiditan) and Zecuity (rizatriptan) are selective serotonin receptor agonists used to treat migraine headaches. Reyvow and Zecuity are not indicated for the preventive treatment of migraine.

Reyvow is a type of migraine medicine called a ditan, while Zecuity is a triptan.

Side effects of Reyvow and Zecuity that are similar include dizziness, sedation/drowsiness, fatigue/tired feeling, feelings of numbness/tingling/numbness/prickling/heat, and nausea.

Side effects of Reyvow that are different from Zecuity include vomiting.

Side effects of Zecuity that are different from Reyvow include mild headache (not a migraine), dry mouth; feeling of pain or tightness in the jaw, neck, or throat; pressure or heavy feeling in any part of your body, weakness, and flushing (warmth, redness, or tingling feeling under your skin).

Both Reyvow and Zecuity may interact with antidepressants.

Reyvow may also interact with alcohol or other CNS depressants, MAO inhibitors, trazodone, dextromethorphan, St. John's wort, medications that lower heart rate, and P-gp or BCRP substrates.

Zecuity may also interact with other migraine headache medicines and propranolol.

What Are Possible Side Effects of Reyvow?

Common side effects of Reyvow include:

  • dizziness,
  • fatigue,
  • numbness and tingling,
  • sedation,
  • nausea, and
  • vomiting

What Are Possible Side Effects of Zecuity?

Common side effects of Zecuity include:

  • application site skin reactions including pain,
  • itching,
  • tingling or numbness,
  • discomfort,
  • warmth,
  • discoloration,
  • irritation,
  • bruising,
  • dermatitis (rash),
  • skin lesions,
  • changes in skin color, or
  • cysts.

What Is Reyvow?

Reyvow (lasmiditan) is a serotonin (5-HT) 1F receptor agonist indicated for the acute treatment of migraine with or without aura in adults. Reyvow is not indicated for the preventive treatment of migraine.

What Is Zecuity?

Zecuity (sumatriptan) is a transdermal system (patch) selective serotonin receptor agonist used to treat acute migraine with or without aura in adults.

QUESTION

Who suffers more frequently from migraine headaches? See Answer

What Drugs Interact With Reyvow?

Reyvow may interact with:

  • alcohol or other CNS depressants,
  • antidepressants,
  • MAO inhibitors,
  • trazodone,
  • dextromethorphan,
  • St. John's wort,
  • medications that lower heart rate, and
  • P-gp or BCRP substrates

What Drugs Interact With Zecuity?

Zecuity may interact with selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) such as:

These medications can cause a potentially life-threatening condition called serotonin syndrome.

Zecuity may also interact with:

  • ergot drugs,
  • monoamine oxidase inhibitors (MAOIs), and
  • other 5-HT1 drugs such as triptans

Tell your doctor all medications and supplements you use.

How Should Reyvow Be Taken?

The recommended dose of Reyvow is 50 mg, 100 mg, or 200 mg taken orally, as needed. No more than one dose of Reyvow should be taken in 24 hours.

How Should Zecuity Be Taken?

Zecuity delivers 6.5 mg of sumatriptan in a transdermal system (patch) over a period of 4 hours. No more than two Zecuity patches should be used in any 24-hour period. A second Zecuity patch should be used no sooner than 2 hours after activation of first.

SLIDESHOW

16 Surprising Headache Triggers and Tips for Pain Relief See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Lilly. Reyvow Drug Information.

https://investor.lilly.com/news-releases/news-release-details/lillys-reyvowtm-lasmiditan-first-and-only-medicine-new-class

Teva Pharmaceuticals. Zecuity Product Information.

https://www.zecuity.com/

Health Solutions From Our Sponsors